FRESENIUS MEDICAL CARE AG Dividends Paid Classified As Financing Activities
FRESENIUS MEDICAL CARE AG (FMS) reported Dividends Paid Classified As Financing Activities of EUR 351.17 million for the 9-month period ending 2020-09-30, per its 6-K filed 2020-10-29.
Discontinued › Cash Flow › Financing Activities
ifrs-full:DividendsPaidClassifiedAsFinancingActivities · last filed 2020-10-29
- FRESENIUS MEDICAL CARE AG dividends paid classified as financing activities for the quarter ending 2019-12-31 was 0.00 EUR.
- FRESENIUS MEDICAL CARE AG dividends paid classified as financing activities for the quarter ending 2019-09-30 was 0.00 EUR, a 100.00% decline year-over-year.
- FRESENIUS MEDICAL CARE AG dividends paid classified as financing activities for the quarter ending 2018-12-31 was 0.00 EUR.
- FRESENIUS MEDICAL CARE AG dividends paid classified as financing activities for the quarter ending 2018-09-30 was 649.68M EUR.
| Period end | Dividends Paid Classified As Financing Activities 3 month | Dividends Paid Classified As Financing Activities 6 month | Dividends Paid Classified As Financing Activities 6 month as first filed | Dividends Paid Classified As Financing Activities 9 month | Dividends Paid Classified As Financing Activities 12 month | Dividends Paid Classified As Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-09-30 | 351.17M EUR 6-K · filed 2020-10-29 | |||||
| 2019-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 0.00 EUR derived: sum of 2 quarters · filed 2020-10-29 | 354.64M EUR 20-F · filed 2020-02-20 | |||
| 2019-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-10-29 | 354.64M EUR 6-K · filed 2020-10-29 | ||||
| 2019-06-30 | 354.64M EUR 6-K · filed 2020-07-30 | -354.64M EUR 6-K · filed 2019-07-30 | ||||
| 2018-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 649.68M EUR derived: sum of 2 quarters · filed 2020-02-20 | 324.84M EUR 20-F · filed 2020-02-20 | -324.84M EUR 20-F · filed 2019-02-20 | ||
| 2018-09-30 | 649.68M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 324.84M EUR 6-K · filed 2019-10-31 | ||||
| 2018-06-30 | -324.84M EUR 6-K · filed 2019-07-30 | 324.84M EUR 6-K · filed 2018-08-01 | ||||
| 2017-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 0.00 EUR derived: sum of 2 quarters · filed 2020-02-20 | 293.97M EUR 20-F · filed 2020-02-20 | |||
| 2017-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-10-30 | 293.97M EUR 6-K · filed 2018-10-30 | ||||
| 2017-06-30 | 293.97M EUR 6-K · filed 2018-08-01 | |||||
| 2016-12-31 | -244.25M EUR 20-F · filed 2019-02-20 | 244.25M EUR 20-F · filed 2018-02-27 | ||||
| 2015-12-31 | 236.77M EUR 20-F · filed 2018-02-27 |